Revenue rose from KRW 118.1 billion in 2022 to KRW 134.2 billion in 2023 (up 13.7%), KRW 138.2 billion in 2024 (up 2.9%) and KRW 162.1 billion in 2025 (up 17.3%), and it has grown three years in a row from 2023 through 2025. 2025 was the largest year of 2022–2025.
Operating profit went from KRW 24.7 billion in 2022 to KRW 28.5 billion in 2023 (up 15.4%), fell to KRW 26.2 billion in 2024 (down 8.2%), and recovered to KRW 28.9 billion in 2025 (up 10.7%).
Operating margin declined from 20.9% in 2022 and 21.2% in 2023 to 18.9% in 2024 and 17.9% in 2025, so revenue grew faster than profit as the margin narrowed. The company attributed the 2025 margin decline to larger upfront investment for future growth.
Headcount rose from 321 at the end of 2019 to 618 at the end of 2025, and research staff increased from 88 to 170. Profit attributable to controlling shareholders rose from KRW 25.3 billion in 2022 to KRW 26.7 billion in 2023 and KRW 27.2 billion in 2024, then fell 13.1% to KRW 23.7 billion in 2025.
Net profit including non-controlling interests was KRW 23.9 billion in 2025. Operating cash flow was KRW 23.1 billion in 2022, KRW 34.3 billion in 2023, KRW 24.9 billion in 2024 and KRW 22.1 billion in 2025.
Quarterly operating profit bottomed at KRW 5.05 billion in Q4 2025, down 23.5% from Q3 2025, then rose to KRW 6.8 billion in Q1 2026, KRW 8.24 billion in Q2 and KRW 8.93 billion in Q3, three consecutive quarterly increases.
Profit attributable to controlling shareholders peaked at KRW 9.59 billion in Q1 2026 and then fell to KRW 7.3 billion in Q2 and KRW 2.08 billion in Q3, two consecutive declines. The last four quarters total KRW 20.2 billion.
The reasons for the sharp Q1 swing will be found in non-operating items and tax lines of the next annual report.